Research Library
Peer-reviewed papers from top journals, summarized and graded by evidence strength. Updated Mon, Wed & Fri.
6 papers added this week271 in the library
| Study | Evidence | Type | n | Journal | Date |
|---|---|---|---|---|---|
| This week1 study | |||||
| Ozempic-Style Drugs May Slow Biological Aging, Not Just Shrink WaistlinesGLP-1 drugs like semaglutide cut deaths and heart problems by more than their weight and blood sugar effects alone would explain. | Moderate | Journal Article | — | Experimental gerontology | |
| Jun 15–21, 20262 studies | |||||
| Why GLP-1 Weight Loss Can Cost You Muscle After 60GLP-1 drugs like Ozempic help older adults shed weight, but a lot of that loss can be muscle. | Moderate | Journal Article | — | Current nutrition reports | |
| Tirzepatide Works Just as Well and as Safely for Adults Over 65Tirzepatide is the popular GLP-1 weight loss drug also sold as Mounjaro and Zepbound. | Moderate | Journal Article | 3 | Diabetes, obesity & metabolism | |
Jun 15–21, 2026
2 studiesDisclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.
Common questions
What is the Longevity Research Library?
The Longevity Switzerland Research Library curates recent peer-reviewed studies on longevity, nutrition, exercise, sleep, and supplements. Each study is rated by evidence strength: Strong, Moderate, or Preliminary.
How are evidence levels determined?
Evidence levels are based on study type (meta-analysis, RCT, cohort study), sample size, journal impact factor, and reproducibility of findings.
Your Weekly Edge
Receive the latest longevity insights, exclusive event invites, and science-backed tips to help you live longer and thrive.
